Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (221-230 of 301) with videos related to

Pageof 31
Sort By:
Human Gene Therapy|November 1, 1995
A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotypeC Melani, J Sulé-Suso, F Arienti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Involvement of somatically acquired ecotropic viruses in the immunogenicity of nude-transplanted NIH/3T3 transformed cell linesM Sensi, M Bergomi, P Panceri, et al.
Biochimica Et Biophysica Acta|December 17, 1986
Immune response to autologous human melanoma: implication of class I and II MHC productsG Fossati, A Anichini, D Taramelli, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cellsM Radrizzani, M Quaia, B Benedetti, et al.
Blood|May 15, 1993
Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytesC Melani, G F Mattia, A Silvani, et al.
The Journal of Experimental Medicine|April 1, 1993
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patientsA Anichini, C Maccalli, R Mortarini, et al.
The Journal of Clinical Investigation|February 15, 1997
Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccineM Sensi, C Farina, C Maccalli, et al.
International Journal of Cancer|September 4, 1995
An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokinesC Melani, S M Pupa, A Stoppacciaro, et al.
Cancer Metastasis Reviews|January 1, 1985
Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cellsG Parmiani, G Fossati, D Taramelli, et al.
International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.
Pageof 31

Showing results (221-230 of 301) with videos related to

Sort By:
Pageof 31
Human Gene Therapy|November 1, 1995
A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotypeC Melani, J Sulé-Suso, F Arienti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Involvement of somatically acquired ecotropic viruses in the immunogenicity of nude-transplanted NIH/3T3 transformed cell linesM Sensi, M Bergomi, P Panceri, et al.
Biochimica Et Biophysica Acta|December 17, 1986
Immune response to autologous human melanoma: implication of class I and II MHC productsG Fossati, A Anichini, D Taramelli, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cellsM Radrizzani, M Quaia, B Benedetti, et al.
Blood|May 15, 1993
Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytesC Melani, G F Mattia, A Silvani, et al.
The Journal of Experimental Medicine|April 1, 1993
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patientsA Anichini, C Maccalli, R Mortarini, et al.
The Journal of Clinical Investigation|February 15, 1997
Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccineM Sensi, C Farina, C Maccalli, et al.
International Journal of Cancer|September 4, 1995
An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokinesC Melani, S M Pupa, A Stoppacciaro, et al.
Cancer Metastasis Reviews|January 1, 1985
Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cellsG Parmiani, G Fossati, D Taramelli, et al.
International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.
Pageof 31